44 results
424B4
BIOCQ
Biocept Inc
25 May 23
Prospectus supplement with pricing info
5:23pm
to further explore these observations in a prospective clinical trial.
Recent Developments
On May 11, 2023, at a special meeting of stockholders, our … by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66
8-K
BIOCQ
Biocept Inc
16 May 23
Material Modifications to Rights of Security Holders
9:11am
was authorized by the stockholders of the Company at the Company’s special meeting of stockholders on May 11, 2023.
The Amendment provides
8-K
w9wfcsraghblkp85m9pc
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
DEFR14A
rctb 8rh0z
21 Apr 23
Revised proxy
8:30am
424B5
suugw4a3c qo
13 May 21
Prospectus supplement for primary offering
6:03am
424B5
nagxmxsgn
15 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
6tlz911se913bp102
5 Mar 20
Prospectus supplement for primary offering
8:46am
424B5
88g d45gx942yflzm
2 Mar 20
Prospectus supplement for primary offering
5:16pm